Adolor Corporation to Present at the Cowen and Company 31st Annual Health Care Conference
March 02 2011 - 2:00PM
Business Wire
Adolor Corporation (NasdaqGM: ADLR) today announced that Michael
R. Dougherty, President and Chief Executive Officer, will present
at the Cowen and Company 31st Annual Health Care Conference on
Monday, March 7, 2011, at 1:45 P.M. Eastern Time. The conference is
being held at the Boston Marriott Copley Place, Boston,
Massachusetts.
Adolor’s presentation will be webcast live on the investor
relations section of the Company’s website and will be archived for
one week following the broadcast. To access the webcast, log onto
the Company’s website at www.adolor.com and click on “Investor
Insights,” then “Webcast.” Click on the link and follow the prompts
for registration and access.
About Adolor
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain and pain management products.
Adolor’s first approved product in the United States is ENTEREG®
(alvimopan), which is indicated to accelerate the time to upper and
lower gastrointestinal recovery following partial large or small
bowel resection surgery with primary anastomosis. ENTEREG is
available for short-term use in hospitals registered under the
E.A.S.E.® Program. For more information on ENTEREG, including its
full prescribing information, visit www.ENTEREG.com. In
collaboration with GSK, the Company launched ENTEREG in
mid-2008.
The Company's research and development pipeline includes:
ADL5945 and ADL7445, novel mu opioid receptor antagonists
undergoing clinical development for chronic OIC; and several
earlier-stage compounds under development for the management of
pain and CNS disorders.
For more information, visit www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024